Watch Demo

Belgium Anti-Infective Industry Outlook 2022 - 2026

See how Belgium Anti-Infective performed compared to key markets such as the United Kingdom, Germany and South Korea.

Key Market Indicators

The country came in number 9 in 2021, Ireland overtook at $561,370,000. Germany, France and Italy respectively were numbers 2, 3 and 4 in this ranking. Sales of antiinfective medicine in Belgium is projected to reach $863 million by 2026, up 0.9% annually from 2021's total of $830 million. Since 2007, Belgium's market has grown 3.4% year on year. Greece overtook Belgium in 2021, with a total of $830 million, while Germany, South Korea and Italy came in second, third and fourth, respectively. Belgium's antibiotic exports are projected to reach $579 million by 2026, down 0.7% year on year on average. Since 2004, the country's supply has declined 1.7% annually. India overtook Belgium in 2021, with $613 million, while Switzerland, Italy and India were second, third and fourth, respectively. Belgium's antibiotic imports are estimated to reach $524 million by 2026, down 0.8% year on year on average. Since 2004, the country's demand has been decreasing 3.6% annually. Ireland overtook Belgium in 2021, with a total of $561 million, while Germany, France and Italy were second, third and fourth, respectively.

Marketing Banner

Belgium Anti-Infective Market Data and Forecasts

How much will Belgium Anti-Infective Market grow to 2026?

Forecast: Antiinfective Medicine Sales in Belgium
Forecast: Antibacterial Medicine Sales in Belgium
Forecast: Antibacterial Medicine Sales in Belgium
More in Anti-Infective Industry for 2028

Improve your Knowledge with the latest Indicators and Trends